Showing results (31-40 of 1,474) with videos related to
Sort By:
Pageof 148
Clinical Neuropharmacology|July 15, 2000
Akathisia and exacerbation of psychopathology: a preliminary reportE J Duncan, L A Adler, M Stephanides, et al.Psychopharmacology Bulletin|January 1, 1997
Interrater reliability issues in multicenter trials, Part II: Statistical procedures used in Department of Veterans Affairs Cooperative Study #394R Edson, P Lavori, K Tracy, et al.The American Journal of Psychiatry|August 1, 1978
Suppression of prolactin by dopamine agonists in schizophrenics and controlsJ Rotrosen, B Angrist, C Clark, et al.Psychopharmacology|January 1, 1987
Double blind controlled trials of cholecystokinin octapeptide in neuroleptic-refractory schizophreniaE Peselow, B Angrist, A Sudilovsky, et al.Psychopharmacology|January 1, 1987
Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomographyA Wolkin, B Angrist, A Wolf, et al.Journal of Attention Disorders|January 27, 2005
Attention-deficit/hyperactivity disorder in adult patients with posttraumatic stress disorder (PTSD): is ADHD a vulnerability factor?L A Adler, M Kunz, H C Chua, et al.Psychiatry Research|May 1, 1991
Stability of resting deoxyglucose metabolic values in PET studies of schizophreniaE J Bartlett, F Barouche, J D Brodie, et al.The British Journal of Psychiatry : the Journal of Mental Science|November 1, 1979
Neuroendocrine effects of apomorphine: characterization of response patterns and application to schizophrenia researchJ Rotrosen, B Angrist, S Gershon, et al.The American Journal of Psychiatry|February 1, 1988
Low frontal glucose utilization in chronic schizophrenia: a replication studyA Wolkin, B Angrist, A Wolf, et al.Journal of Neural Transmission. General Section|January 1, 1994
Persistent psychosis after reduction in pre- and post-synaptic dopaminergic functionA Wolkin, E Duncan, M Sanfilipo, et al.Pageof 148